These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17324265)

  • 1. Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.
    Shadrina MI; Semenova EV; Slominsky PA; Bagyeva GH; Illarioshkin SN; Ivanova-Smolenskaia II; Limborska SA
    BMC Med Genet; 2007 Feb; 8():6. PubMed ID: 17324265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.
    Elfferich P; Verleun-Mooijman MC; Maat-Kievit JA; van de Warrenburg BP; Abdo WF; Eshuis SA; Leenders KL; Hovestadt A; Zijlmans JC; Stroy JP; van Swieten JC; Boon AJ; van Engelen K; Verschuuren-Bemelmans CC; Lesnik-Oberstein SA; Tassorelli C; Lopiano L; Bonifati V; Dooijes D; van Minkelen R
    Neurogenetics; 2011 Nov; 12(4):263-71. PubMed ID: 21993715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of deletion mutations in the PARK2 gene in idiopathic Parkinson's disease].
    Slominskiĭ PA; Miloserdova OV; Popova SN; Giliazova IR; Khidiiatova IV; Magzhanov RV; Khusnutdinova EK; Limborskaia SA
    Genetika; 2003 Feb; 39(2):223-8. PubMed ID: 12669418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease.
    Semenova EV; Shadrina MI; Slominsky PA; Ivanova-Smolenskaya IA; Bagyeva G; Illarioshkin SN; Limborska SA
    Mov Disord; 2012 Jan; 27(1):139-42. PubMed ID: 21915905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
    Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
    Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
    Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
    Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.
    Koziorowski D; Hoffman-Zacharska D; Sławek J; Szirkowiec W; Janik P; Bal J; Friedman A
    Parkinsonism Relat Disord; 2010 Feb; 16(2):136-8. PubMed ID: 19628420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
    van der Merwe C; Carr J; Glanzmann B; Bardien S
    Neurosci Lett; 2016 Apr; 619():168-71. PubMed ID: 27001088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.
    Huang T; Gao CY; Wu L; Gong PY; Wang JZ; Tian YY; Zhang YD
    Brain Behav; 2019 Sep; 9(9):e01372. PubMed ID: 31386307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.
    Kim SY; Seong MW; Jeon BS; Kim SY; Ko HS; Kim JY; Park SS
    Clin Genet; 2012 Jul; 82(1):77-82. PubMed ID: 21534944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
    Sinha R; Racette B; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of Parkin exon rearrangements in Mexican-mestizo patients with early-onset Parkinson's disease.
    Guerrero Camacho JL; Monroy Jaramillo N; Yescas Gómez P; Rodríguez Violante M; Boll Woehrlen C; Alonso Vilatela ME; López López M
    Mov Disord; 2012 Jul; 27(8):1047-51. PubMed ID: 22777964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution, type, and origin of Parkin mutations: review and case studies.
    Hedrich K; Eskelson C; Wilmot B; Marder K; Harris J; Garrels J; Meija-Santana H; Vieregge P; Jacobs H; Bressman SB; Lang AE; Kann M; Abbruzzese G; Martinelli P; Schwinger E; Ozelius LJ; Pramstaller PP; Klein C; Kramer P
    Mov Disord; 2004 Oct; 19(10):1146-57. PubMed ID: 15390068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.
    Monroy-Jaramillo N; Guerrero-Camacho JL; Rodríguez-Violante M; Boll-Woehrlen MC; Yescas-Gómez P; Alonso-Vilatela ME; López-López M
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):235-44. PubMed ID: 24677602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations.
    Hedrich K; Marder K; Harris J; Kann M; Lynch T; Meija-Santana H; Pramstaller PP; Schwinger E; Bressman SB; Fahn S; Klein C
    Neurology; 2002 Apr; 58(8):1239-46. PubMed ID: 11971093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic instability in the PARK2 locus is associated with Parkinson's disease.
    Ambroziak W; Koziorowski D; Duszyc K; Górka-Skoczylas P; Potulska-Chromik A; Sławek J; Hoffman-Zacharska D
    J Appl Genet; 2015 Nov; 56(4):451-461. PubMed ID: 25833766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.
    Lin Y; Zeng YF; Cai NQ; Lin XZ; Wang N; He J
    Eur Neurol; 2019; 81(5-6):246-253. PubMed ID: 31618739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients.
    Djarmati A; Hedrich K; Svetel M; Schäfer N; Juric V; Vukosavic S; Hering R; Riess O; Romac S; Klein C; Kostic V
    Hum Mutat; 2004 May; 23(5):525. PubMed ID: 15108293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin mutations in familial and sporadic Parkinson's disease among Indians.
    Chaudhary S; Behari M; Dihana M; Swaminath PV; Govindappa ST; Jayaram S; Goyal V; Maitra A; Muthane UB; Juyal RC; Thelma BK
    Parkinsonism Relat Disord; 2006 May; 12(4):239-45. PubMed ID: 16500134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary studies on parkin gene deletion at exons 1 to 6 in Chinese patients with praecox Parkinson's disease].
    Bia H; Shao M; Dong X; Yang J; Gao Q; Li Y; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Oct; 17(5):323-5. PubMed ID: 11024210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.